US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Pantoprazole Sodium Delayed-Release Tablets

Reason Discoloration: Expansion of an earlier recall due to the presence of dark brown discoloration on the edges of the tablets.

Jubilant Cadista Pharmaceuticals, Inc. NDC 59746-284-90 D-1074-2019
Class II · Moderate risk Terminated

Phenobarbital Oral Solution

Reason Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Lohxa LLC NDC 70166-536-02 D-1131-2019
Class II · Moderate risk Terminated

Bismuth Subsalicylate Oral Suspension 262mg/15mL

Reason Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Lohxa LLC NDC 70166-059-01 D-1130-2019
Class II · Moderate risk Terminated

Pravastatin Sodium Tablets USP

Reason Presence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg.

Glenmark Pharmaceuticals Inc., USA NDC 68462-196-05 D-1120-2019
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason Presence of Particulate Matter.

InvaGen Pharmaceuticals, Inc. NDC 69097-536-37 D-1125-2019
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason Presence of Particulate Matter.

InvaGen Pharmaceuticals, Inc. NDC 69097-537-31 D-1124-2019
Class II · Moderate risk Terminated

Testosterone Cypionate Injection

Reason Presence of Particulate Matter.

InvaGen Pharmaceuticals, Inc. NDC 69097-537-37 D-1123-2019
Class II · Moderate risk Terminated

Fayosim

Reason Failed Impurities/Degradation Specifications: Out-of-specification results observed in related substance test (Any Other Individual Impurity and Total impurities) in Ethinyl Estradiol Tablets USP 0.01mg at 12 month long term stability study.

Lupin Pharmaceuticals Inc. NDC 68180-860-11 D-1057-2019
Class II · Moderate risk Terminated

Gavilyte-N

Reason Labeling Not Elsewhere Classified; orange and cherry flavor packets incorrect list "natural lemon flavor" as an ingredient

Lupin Somerset NDC 43386-050-19 D-1113-2019
Class II · Moderate risk Terminated

Combigan

Reason cGMP Deviations

Allergan Sales, LLC NDC 0023-9211-05 D-1056-2019
Class II · Moderate risk Terminated

Losartan 50mg Tablet

Reason CGMP Deviations; Detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) - N-Methylnitrosobutyric acid (NMBA).

RemedyRepack Inc. D-1081-2019
Class II · Moderate risk Terminated

Phenylephrine HCl

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. D-1034-2019
Class II · Moderate risk Terminated

Morphine Sulfate 30 mg/30 mL

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. D-1033-2019
Class II · Moderate risk Terminated

Phenylephrine HCl

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. D-1032-2019
Class II · Moderate risk Terminated

Heparin 5

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. D-1031-2019
Class II · Moderate risk Terminated

Phenylephrine HCl

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. D-1028-2019
Class II · Moderate risk Terminated

Glycopyrrolate 0.6 mg/3 mL

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. D-1025-2019
Class II · Moderate risk Terminated

Phenylephrine HCl

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. D-1023-2019
Class II · Moderate risk Terminated

Phenylephrine HCl

Reason Lack of Assurance of Sterility

Advanced Pharma Inc. D-1022-2019